Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions.
about
Drug treatment of non-motor symptoms in Parkinson's disease.Pharmacotherapy in the management of early Parkinson's disease: cost-effectiveness and patient acceptability.Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up.How should we treat a patient with early Parkinson's disease?Drug and treatment costs in Parkinson's disease patients in Sweden.Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson's disease using [11C]PBR28 and [18F]FDOPA PET.Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
P2860
Q34122222-6146A491-92FE-4683-AB8A-02E0C4688591Q35205344-E9D547C6-4744-4C28-82CB-89B64140B64EQ35487919-99805554-DE97-4A97-9FD7-A3B7340F35AEQ37775098-54D19F46-20D4-49E8-B1DC-94AB4904C447Q39763335-389F5380-D392-4694-BF9D-F854568BF956Q47260664-B52C1D00-FAB5-46C4-9A2D-0446A04EA94BQ50770517-0734BA78-3157-4D31-A282-B321A6C7C104
P2860
Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cost-effectiveness analysis in ...... ng the value of interventions.
@ast
Cost-effectiveness analysis in ...... ng the value of interventions.
@en
type
label
Cost-effectiveness analysis in ...... ng the value of interventions.
@ast
Cost-effectiveness analysis in ...... ng the value of interventions.
@en
prefLabel
Cost-effectiveness analysis in ...... ng the value of interventions.
@ast
Cost-effectiveness analysis in ...... ng the value of interventions.
@en
P2093
P2860
P1433
P1476
Cost-effectiveness analysis in ...... ng the value of interventions.
@en
P2093
A D Siderowf
R G Holloway
P2860
P304
P356
10.1002/1531-8257(200005)15:3<439::AID-MDS1004>3.0.CO;2-F
P407
P577
2000-05-01T00:00:00Z